S&P 500: 681.75 +0.1% NASDAQ 100: 601.92 +0.2% Dow Jones: 495.28 +0.1%

Rapport Therapeutics, Inc.

RAPP 醫療健康
$27.93 $-0.04 (-0.14%)
Market Cap: $1.33 B
Gurus Holding
3
Popularity Rank
#2950
% of Shares Held
0.32%
Net Activity (Q4 2025)
+$2.53 M

Guru Ownership Trend

Guru Analysis for Rapport Therapeutics, Inc. (RAPP)

Rapport Therapeutics, Inc. (RAPP), a key player in the 醫療健康 sector, continues to attract institutional attention.

As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $4.21 M.

Top institutional holders include 文藝復興科技 and 克里夫·阿斯內斯.

Institutional sentiment is currently Bullish. This is evidenced by a $2.53 M net inflow during the quarter.

Recent activity highlights 文藝復興科技 who increased their stake by 236.6%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$2.53 M
Total Buy Value
New Buys 0
Additions 1
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
0
Net Buyers
1

FAQs for Rapport Therapeutics, Inc. (RAPP)

Major holders include 文藝復興科技 ($3.6 M), 克里夫·阿斯內斯 ($612,474), 保羅·都鐸·瓊斯 ($331,125). According to the latest reported data, 3 tracked investment managers collectively hold approximately 150,585 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.53 M, with 1 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in RAPP during the most recent reporting period.

Yes, 0 managers opened new positions in RAPP, and 1 increased their existing holdings. The total reported buy value was $2.53 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Add 236.6% 118,814 $3.6 M Q4 2025
0.00% Add 21.5% 20,622 $612,474 Q3 2025
0.00% New Buy 11,149 $331,125 Q3 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form